Search across the website

Find training courses, blog posts, guidelines, knowledge base articles and more.

to navigate esc to close to open

Guideline Knowledge Base

Search authoritative versions, compare publication history, and download source files from a single client-ready portal.

Available Guidelines

17 matches

  • Good documentation constitutes an essential part of the quality assurance system and is key to operating in compliance with GMP requirements. The various types of documents and media used should be fully defined in the manufacturer's Quality Management System. Documentation may exist in a variety of forms, including paper-based, electronic or photographic media. The main objective of the system of documentation utilized must be to establish, control, monitor and record all activities which directly or indirectly impact on all aspects of the quality of medicinal products. The Quality Management System should include sufficient instructional detail to facilitate a common understanding of the requirements, in addition to providing for sufficient recording of the various processes and evaluation of any observations, so that ongoing application of the requirements may be demonstrated.

    Date into Effect: GMP EMA
  • Premises and equipment must be located, designed, constructed, adapted and maintained to suit the operations to be carried out. Their layout and design must aim to minimise the risk of errors and permit effective cleaning and maintenance in order to avoid cross-contamination, build-up of dust or dirt and, in general, any adverse effect on the quality of products.

    Date into Effect: GMP EMA
  • The holder of a Manufacturing Authorisation must manufacture medicinal products so as to ensure that they are fit for their intended use, comply with the requirements of the Marketing Authorisation or Clinical Trial Authorisation, as appropriate and do not place patients at risk due to inadequate safety, quality or efficacy.

    Date into Effect: GMP EMA
  • The correct manufacture of medicinal products relies upon people. For this reason there must be sufficient qualified personnel to carry out all the tasks which are the responsibility of the manufacturer. Individual responsibilities should be clearly understood by the individuals and recorded. All personnel should be aware of the principles of Good Manufacturing Practice that affect them and receive initial and continuing training, including hygiene instructions, relevant to their needs.

    Date into Effect: GMP EMA
  • This Annex deals with the manufacture of active substance gases and with the manufacture of medicinal gases.

  • This Annex describes the principles of qualification and validation which are applicable to the facilities, equipment, utilities and processes used for the manufacture of medicinal products and may also be used as supplementary optional guidance for active substances without introduction of additional requirements to EudraLex, Volume 4, Part II.

    Date into Effect: GMP + GDP EMA Qualification & Validation
Newsletter Sign-up

Get Guideline Updates in Your Inbox

Subscribe for major GMP/GDP guideline changes, new publications and timeline updates.

We care about your data. Read our privacy policy .